Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

Simple item page
dc.coverageDOI: 10.4254/wjh.v14.i2.319
dc.creatorF, Paulina Núñez
dc.creatorCastro, Fabiola
dc.creatorMezzano, Gabriel
dc.creatorQuera, Rodrigo
dc.creatorDiaz, Diego
dc.creatorCastro, Lorena
dc.date2022
dc.date.accessioned2025-11-18T19:41:50Z
dc.date.available2025-11-18T19:41:50Z
dc.description<p>Inflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. The prevalence of liver dysfunction can reach up to 50% in different studies. Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD, while primary sclerosing cholangitis is the most specific. Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists. The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD, associated diseases or to the therapies used.</p>eng
dc.descriptionInflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. The prevalence of liver dysfunction can reach up to 50% in different studies. Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD, while primary sclerosing cholangitis is the most specific. Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists. The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD, associated diseases or to the therapies used.spa
dc.descriptionInflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. The prevalence of liver dysfunction can reach up to 50% in different studies. Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD, while primary sclerosing cholangitis is the most specific. Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists. The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD, associated diseases or to the therapies used.eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/5545d918-9b11-4084-b854-b9954a8bae82
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/52021
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.14 (2022) date: 2022-02-27 nr.2 p.319-337
dc.subjectExtraintestinal manifestations
dc.subjectHepatic steatosis
dc.subjectInflammatory bowel disease
dc.subjectLiver toxicity
dc.subjectSclerosing primary cholangitis
dc.subjectExtraintestinal manifestations
dc.subjectHepatic steatosis
dc.subjectInflammatory bowel disease
dc.subjectLiver toxicity
dc.subjectSclerosing primary cholangitis
dc.titleHepatobiliary manifestations in inflammatory bowel disease: A practical approacheng
dc.typeReview articleeng
dc.typeArtículo de revisiónspa
Files
Collections
PURE